CymaBay Therapeutics, Inc.

Squarepoint Ops LLC

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

93,133

Value ($000)

2,200

Weight

0.0%

2019 Q4 - 2023 Q4 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	2,200	0.0%	93,133	12/31/2023
2023 Q3	11/14/2023	1,251	0.0%	83,901	9/30/2023
2023 Q2	8/14/2023	1,118	0.0%	102,133	6/30/2023
2023 Q1	5/15/2023	819	0.0%	93,882	3/31/2023
2022 Q4	2/14/2023	63	0.0%	10,027	12/31/2022
2022 Q3	11/14/2022	61	0.0%	17,495	9/30/2022
2021 Q4	2/14/2022	35	0.0%	10,273	12/31/2021
2021 Q3	11/15/2021	51	0.0%	13,995	9/30/2021
2021 Q2	8/16/2021	188	0.0%	43,127	6/30/2021
2021 Q1	5/17/2021	294	0.0%	64,671	3/31/2021
2020 Q4	2/16/2021	882	0.0%	153,593	12/31/2020
2020 Q3	11/16/2020	380	0.0%	52,501	9/30/2020
2020 Q2	8/14/2020	953	0.0%	273,172	6/30/2020
2020 Q1	5/15/2020	266	0.0%	179,573	3/31/2020
2019 Q4	2/14/2020	240	0.0%	122,532	12/31/2019